Human Apolipoprotein H Antibody (IgA) ELISA Kit (Sandwich ELISA)
Catalog Number: LS-F67373-1
1 plate / $591.00
Reactivity: Human
Detection Method Colorimetric
Format: 96-Well Strip Plate
SLC22A1 Antibody western blot of HepG2 cell line lysates (35 ug/lane). The SLC22A1 antibody detected the SLC22A1 protein (arrow).
SLC22A1 Antibody (aa511-539)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunohistochemistry (general), Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$401.00each
Catalog Number: LS-C161155-400
Catalog Number: LS-C161155
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- SLC22A1 antibody LS-C161155 is an unconjugated rabbit polyclonal antibody to human SLC22A1 (aa511-539). Validated for WB. Cited in 2 publications.
- Application
- IHC, WB
- Reactivity
- Hu
- Intended Use
- RUO
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- HOCT1 | OCT1 | Oct1_cds | Organic cation transporter 1 | SLC22A1
- Recommended Dilution: WB
- 1:1000
- UniProt Number
- O15245
- NCBI GenBank
- NM_003057, NP_003048.1
- SwissProt
- O15245
Target
- Target
- Human SLC22A1
- Antigen Species
- Hu
- Epitope
- This SLC22A1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 511-539 amino acids from the C-terminal region of human SLC22A1.
- Gene Name
- SLC22A1
Antibody
- Host Species
- Rb
- Clonality
- Polyclonal
Immunogen
- Immunogen
- KLH conjugated synthetic peptide between 511-539 amino acids from the C-terminal region of human SLC22A1
- Immunogen Type
- SP-Lin
Format
- Conjugate/Label
- Unconj
- Format
- Liquid
- Formulation
- PBS, 0.09% Sodium Azide
- Concentration
- 0.4 mg/mL
- Volume
- 400 Microliter
- Preservative
- Yes
Storage & Handling
- Storage Conditions
- Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.
- Recommended Storage Buffer
- PBS
The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma. Geier A, Macias RI, Bettinger D, Weiss J, Bantel H, Jahn D, Al-Abdulla R, Marin JJ. Oncotarget. 2017 February;8:15846-15857. PubMed: 28178663 PMC: PMC5362528
